The role of protein kinase C (PKC) as a mediator of glucose-induced insulin secretion has been a subject of controversy. Glucose-induced translocation of PKC has not been reported, and the relevant PKC isoenzymes in islets have not been identified. To address these issues, we developed specific antibodies to the a, /3, and y isoenzymes of PKC. Western blots of homogenates of freshly isolated rat islets probed with these antibodies revealed that the major isoenzyme present is a-PKC. Islets were perifused for 15 min with either 2.75 mM glucose, 20 mM glucose, 20 mM glucose plus 30 mM mannoheptulose, 15 mM a-ketoisocaproate, or a-ketoisocaproate plus mannoheptulose. Quantitative immunoblotting of membrane and cytosol fractions showed that a-PKC translocated from the cytosol to the membrane in freshly isolated rat islets stimulated with either 20 mM glucose or 15 mM ac-ketoisocaproate. Both the secretory response and the translocation of a-PKC were blocked by the addition of mannoheptulose, an inhibitor of glucose metabolism, in islets stimulated with glucose but not in islets stimulated with a-ketoisocaproate. These results support a role for a-PKC in mediating glucoseinduced insulin secretion in pancreatic islets.
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The protein kinase C (PKC) family of enzymes is thought to play an important role in the calcium-dependent activation of many cellular responses (1) . A PKC-like enzyme activity exists in isolated pancreatic islets (2) , and there is substantial indirect evidence that the activation of PKC is involved in glucose-induced insulin secretion (3) . This evidence includes reports that exposure of isolated islets to stimulatory glucose concentrations leads to the accumulation of diacylglycerol (4, 5) , a natural activator of PKC; that phorbol esters, specific pharmacological activators of PKC (6) , induce a slowly increasing rate of insulin secretion similar to the second phase of glucose-induced insulin secretion (7) ; that both phorbol esters and glucose induce the phosphorylation of an 80-kDa PKC substrate protein in mouse islets (8) ; that glyceraldehyde, a fuel secretagogue of insulin secretion in RIN rat insulinoma cells, causes the translocation of PKC from cytosol to membrane in RIN cells (9) ; and that staurosporine, a specific PKC inhibitor, can block glucose-induced insulin secretion (10) . However, direct evidence of PKC activation during glucose-induced insulin secretion is lacking.
In many tissues the activation of PKC is associated with its translocation from the cytosol to a membrane-associated state (11) . To more closely examine the role of PKC in insulin secretion, we developed a protocol to analyze the membrane/cytosol distribution of PKC in rat islets and correlate any change in distribution with changes in the insulin secretory response. To achieve this we developed specific antibodies to the a, /3, and y isoenzymes of PKC. These antibodies were used in Western blotting experiments to identify the PKC isoenzyme or isoenzymes present in rat islets and then to examine the membrane/cytosol distribution of these isoenzymes in freshly isolated, perifused rat pancreatic islets. We have been able to demonstrate that a vigorous, biphasic insulin secretory response induced by either glucose or a-ketoisocaproate (KIC) is associated with a significant translocation of a-PKC immunoreactivity from a cytosolic to a membrane fraction.
EXPERIMENTAL PROCEDURES
Antibody Preparation. Specific antisera to the a, /3, and y isoenzymes of PKC were produced following the technique of Makowske et al. (12) . Oligopeptides of sequences that are specific to the a, /3 (common to both /31 and /32), or y isoenzymes were synthesized by Multiple Peptide Systems (San Diego, CA). The sequences, derived from the region of PKC that bridges the regulatory and catalytic domains, were as follows: a, AGNKVISPSEDRRQ; /, GPKTPEEKTAN-TISKFD (common to both 13i and 832 isoenzymes); 'y, NY-PLELYERVRTG. Each was synthesized with a carboxylterminal cysteine for coupling to a carrier protein.
The peptides were linked to keyhole limpet hemocyanin by using m-maleimidobenzoyl N-hydroxysuccimide ester and were then used to immunize rabbits by subcutaneous injection. The antibodies were affinity-purified on 1-ml columns containing the appropriate oligopeptide coupled to epoxyactivated Sepharose. A 400-Al aliquot of antiserum was loaded onto the appropriate column that had been preequilibrated with Hepes-buffered saline (10 mM Hepes, pH 7.4/ 100 mM NaCl/0.02% NaN3). The column was then consecutively washed with 10 ml of Hepes-buffered saline, 4 ml of 3 M MgCI2 (pH 6.0), and 10 ml of Hepes-buffered saline. The antibodies were eluted with 4 ml of 0.2 M glycine/1 M NaCI, pH 2.2, and immediately neutralized to pH 7 with 1 M sodium phosphate, pH 12.0. This eluate was diluted 1:25 for use in immunoblotting.
Rat Brain Cytosol Preparation. The brain was dissected from an anesthetized male Sprague-Dawley rat and was rapidly homogenized in 7.2 ml of 20 mM Tris, pH 7.4/0.25 M sucrose/10 mM EGTA/2 mM EDTA/10 mM 2-mercaptoethanol/50 M leupeptin/1 mM phenylmethanesulfonyl fluoride (PMSF). The homogenate was centrifuged at 100,000 x g for 45 min and the supernatant was collected as rat brain cytosol.
PKC Purification. The cerebral cortex and cerebellum of fresh calfbrains were rapidly homogenized in 20 mM Tris, pH 7.4/0.25 M sucrose/10 mM EGTA/2 mM EDTA/50 A.M Abbreviations: PKC, protein kinase C; KIC, a-ketoisocaproate; PMSF, phenylmethanesulfonyl fluoride; BSA, bovine serum albumin; PMA, phorbol 12-myristate 13-acetate. §To whom reprint requests should be addressed.
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Proc. Natl. Acad. Sci. USA 87 (1990) leupeptin/10 mM 2-mercaptoethanol/1 mM PMSF. The homogenate was centrifuged at 100,000 X g for 45 min. The supernatant was purified by sequential processing on (i) a DEAE-cellulose column, eluted with a linear gradient from 20 to 250 mM NaCI; (ii) a phenyl HPLC column (Bio-Gel TSK phenyl-SOPW, 150 x 21.5 mm; Bio-Rad), eluted with a linear gradient from 600 to 0 mM NaCl; (iii) a gel filtration column [TSK HW-55 (S); EM Science] for desalting; and (iv) a hydroxylapatite HPLC column (Bio-Gel HPHT, 100 x 7.8 mm; Bio-Rad), eluted with a linear gradient from 20 to 300 mM sodium phosphate. Fractions were assayed for PKC activity by measuring lipid-and calcium-dependent phosphorylation of histone (13) . From the final step we obtained two peaks in high yield corresponding to type II (/3) and type III (a) PKC (14) . The a-and 3-PKC were stable for months when frozen at -800C with 10% glycerol and 0.01% Triton X-100.
To obtain purified 'y-PKC, we used the y-PKC antibody to immunoadsorb y-PKC from rat brain cytosol. The y-PKC antibody was incubated with protein A-coupled Sepharose beads. The beads were washed and then incubated with rat brain cytosol in the presence of 0.05% SDS, 0.5% sodium deoxycholate, 0.5% Triton X-100, 1 mM PMSF, 50 tLM leupeptin, 20 mM Tris (pH 7.0), and 100 mM NaCl. After washing, the y-PKC was eluted from the beads with distilled water. The eluate was concentrated on a vortex evaporator (Buchler Instruments) and processed for immunoblotting.
Islet Isolation and Perifusion. The pancreas was dissected from anesthetized male Sprague-Dawley rats weighing 260-360 g that had been fed ad libitum. The pancreas was digested with collagenase (15) , and islets that were free of exocrine tissue contamination were picked manually under a stereomicroscope. To determine which PKC isoenzymes were present, groups of 150-200 islets were immediately sonicated in homogenization buffer (20 mM Tris, pH 7.4/0.5 mM EGTA/50 AM leupeptin/1 mM PMSF/0.1% 2-mercaptoethanol/10 ,uM pepstatin A containing aprotinin at 25 ,4g/ml) and were processed by immunoblotting using the isoenzymespecific PKC antibodies. For the translocation studies, groups of 30-50 islets were loaded onto nylon filters and perifused at a flow rate of 1 ml/min with bicarbonate-buffered medium [115 mM NaCl/5 mM KCI/1 mM MgCl2/2.2 mM CaCI2/0.17% bovine serum albumin (BSA)/24 mM NaHCO3, gassed with 95% 02/5% C02]. The islets were perifused for 30 min with 2.75 mM glucose to establish stable basal insulin secretory rates and were then perifused for 15 min with an appropriate agonist. In control islets the perifusion was continued with 2.75 mM glucose alone. Serial samples of the perifusate were collected for insulin analysis by radioimmunoassay (16) . At the end of the 15-min exposure to the agonist, the islets were immediately sonicated in 200 gl of ice-cold homogenization buffer and centrifuged in a Beckman Airfuge (25 psi for 10 min; 1 psi = 6.89 kPa). The supernatant was collected as the cytosolic fraction, and the pellet was resuspended in 200 1.l of homogenization buffer and collected as the membrane fraction. The fractions were concentrated by vortex evaporation and processed by immunoblotting using the a-PKC antibody.
Quantitative Immunoblotting. Samples were electrophoresed in SDS/10%o polyacrylamide gels and the separated proteins were electroblotted onto Immobilon-P membranes (Millipore). The membranes were successively incubated with blocking buffer (10 mM sodium phosphate, pH 7.2/150 mM NaCl/3% BSA/0.1% Tween 20) for 30 min at room temperature; with affinity-purified isoenzyme-specific antibody diluted in incubation buffer (10 mM sodium phosphate, pH 7.2/100 mM NaCI/0.1% BSA/0.1% Tween 20/0.05% SDS) for 3 hr at room temperature; and with 1251-labeled protein A (0.5 ,tCi/ml; 1 Ci = 37 GBq) in incubation buffer for 30 min. The membranes were thoroughly washed with 10 mM Tris, pH 7.4/100 mM NaCI/0.1% Tween 20 after each incubation. The membranes were then dried and the immunoreactive bands were visualized by autoradiography. Quantification of the 80-kDa PKC band was done by densitometry on a Visage 2000 system (Biolmage, Ann Arbor, MI) and the results were expressed as (optical density of a-PKC band in the fraction)/(total optical density) x 100, where the total optical density is the sum of the optical density of the a-PKC band in the cytosolic fraction plus the optical density of the a-PKC band in the membrane fraction. P values were calculated using a two-tailed Student's t test.
RESULTS
Characterization of the a-, (3-, and r-PKC Antibodies. The affinity-purified antibodies to the isoenzymes a-, /3-, and y-PKC were shown to specifically recognize the appropriate immunizing peptide by enzyme-linked immunosorbent assay (data not shown). Western blots of purified brain a-, 83-, and y-PKC showed that the antibodies specifically recognized the isoenzyme of PKC corresponding to the peptide against which they were raised (Fig. 1) . These results indicate that the antibodies are isoenzyme-specific and can be used as selective probes for PKC isoenzymes in Western blotting.
Identification of the Major PKC Isoenzyme Present in Rat
Pancreatic Islets. Rat brain contains all three major isoenzymes of PKC (a, /3, and y); all the antibodies recognized an 80-kDa band consistent with PKC in rat brain cytosol ( Fig.  2A) . Whole islet homogenates were processed by immunoblotting to determine which isoenzymes of PKC were present. An 80-kDa band was visualized with the a-PKC antibody, and no bands of the appropriate molecular mass were seen with either the /3-or the y-PKC antibodies (Fig. 2B) . Addition of the a-PKC-specific immunizing peptide effectively blocked the binding of the a-PKC antibody to the 80-kDa band. Although no 80-kDa band was visualized with the 8-PKC antibody, an =50-kDa band was seen. The possibility that it may represent a proteolytic fragment of /3-PKC seems unlikely, as adding a variety of protease inhibitors and high concentrations of EGTA to the homogenization buffer did not alter the apparent molecular mass. It is possible that this 50-kDa band represents a novel protein sharing an epitope with ,3-PKC.
Assessment Thus quantification by densitometry could be used to measure the relative quantity of a-PKC present in samples.
Freshly isolated rat pancreatic islets perifused with a bicarbonate-buffered medium supplemented with 2.75 mM glucose showed low stable rates of insulin secretion (Fig. 3A) . Quantitative immunoblotting of cytosolic and membrane fractions of these unstimulated islets revealed that 87.1 ± 4.3% of the total a-PKC immunoreactivity was localized in the cytosolic fraction and 12.9 ± 4.3% in the membrane (Fig. 3B) . Islets that were perifused with 2.75 mM glucose plus 1 uM PMA showed a slow increase in the rate of insulin secretion (Fig. 3A) . At the end of the 15-min perifusions, fractionation and quantitative immunoblotting of these islets revealed that 50.9 ± 1.3% of the a-PKC immunoreactivity was in the cytosolic fraction and 49.1 ± 1.3% was in the membrane fraction (Fig. 3B) . These results show that the phorbol ester PMA can induce a slow increase in the rate of insulin secretion which is associated with translocation of a-PKC from the cytosol to the membrane. Islets that were perifused with 20 mM glucose exhibited a biphasic insulin secretory response with a >50-fold increase in the secretory rate over control islets perifused with 2.75 mM glucose at 15 min (Fig. 4A) . Fractionation and quantitative immunoblotting of these islets revealed that 48.95 ± 6.92% ofthe total a-PKC was in the cytosol fraction and 51.05 + 6.92% was in the membrane fraction (Fig. 4B) . These values were significantly different from those seen in islets perifused with 2.75 mM glucose. When islets were perifused with 20 mM glucose plus 30 mM mannoheptulose, an inhibitor of glucose metabolism (17) , the brisk biphasic secretory response normally seen with glucose stimulation was abolished (Fig. 4A ). In these islets there was no translocation of a-PKC as compared to control islets, with 82.57 ± 6.81% of the a-PKC signal in the cytosolic fraction and 17.43 ± 6.81% in the membrane fraction (Fig. 4B) .
The translocation of a-PKC was also evident in islets perifused for only 5 min with 20 mM glucose, with 44. Insulin secretion and a-PKC distribution in PMAstimulated rat islets. Freshly isolated islets were perifused for 30 min with a bicarbonate-buffered medium supplemented with 2.75 mM glucose to achieve a low, stable baseline of secretion. The islets were then perifused for 15 min with 2.75 mM glucose plus 1 ,uM PMA (+PMA) or with 2.75 mM glucose alone (G2.75) as an unstimulated control. The islets were then sonicated, separated into membrane and cytosol fractions by centrifugation in a Beckman Airfuge (25 psi for 10 min), and processed by immunoblotting using the a-PKC antibody. The 80-kDa a-PKC band was quantitated by densitometry 
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G20+ MH FIG. 4 . Insulin secretion and a-PKC distribution in glucosestimulated rat islets. Freshly isolated islets were perifused for 30 min with a bicarbonate-buffered medium supplemented with 2.75 mM glucose to achieve a low, stable baseline of secretion. The islets were then perifused for 15 min with 20 mM glucose (G20), with 20 mM glucose plus 30 mM mannoheptulose (G20+MH), or with 2.75 mM glucose alone (G2.75) as an unstimulated control. The islets were then immediately sonicated and processed as described in the legend to Results, expressed as in Fig. 3 , are shown as means + SE (n = 8 for G2.75; n = 6 for G20; n = 3 for G20+MH; P < 0.005 for G20 compared to G2.75). Typical immunoblots showing the relative membrane/cytosol distribution of a-PKC are shown below the bar graph for each experimental condition. Cell Biology: Ganesan et al.
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Cell Biology: Ganesan et al. 13 .5% in the membrane fraction and 55.3 ± 13.5% in the cytosolic fraction (n = 4). Our results confirm the report by Onoda et al. (18) , who showed by immunocytochemistry that a-PKC (type I PKC) is present in pancreatic islets. Onoda Using quantitative immunoblotting with the a-PKC antibody, we have found that a-PKC immunoreactivity translocates from the cytosolic fraction to the membrane fraction in islets perifused with the phorbol ester PMA. This is additional evidence that the 80-kDa band seen by the a-PKC antibody is in fact an isoenzyme of PKC, as it becomes membrane-associated upon exposure to a phorbol ester. This result also validates the quantitative immunoblotting technique as being capable of detecting the translocation of a-PKC in perifused islets.
Using this technique, we have clearly demonstrated that the biphasic insulin secretory response to glucose in freshly isolated pancreatic islets is associated with the translocation of a-PKC from the cytosol to the membrane. This translocation occurs as early as 5 min after exposure to 20 mM glucose. Moreover, this translocation is dependent on the metabolism of glucose, since it can be prevented by the addition of mannoheptulose. Our results differ from those of Persaud et al. (19) and Easom et al. (10) . Neither group was able to demonstrate translocation of PKC enzyme activity from the cytosol to the membrane fraction of isolated islets stimulated with glucose. Differences in methodology may explain the differing results. In both previous studies, islets were cultured overnight and exposed to glucose by batch incubation prior to assessment of PKC translocation. These manipulations may affect the glucose-induced secretory response of the isolated islets. In the studies by Persaud et al. (19) and Easom et al. (10) , cultured islets that had been batch-incubated in high glucose concentrations (20 mM and 16.7 mM, respectively) exhibited a 3-to 4-fold increase in insulin secretory rates when compared with islets incubated in low glucose concentrations. In our studies, islets perifused with 20 mM glucose showed a >30-fold stimulation in secretion at 5 min and a >50-fold stimulation at 15 min when compared with islets perifused with 2.75 mM glucose. This vigorous biphasic secretory response by the islets used in our experiments is similar to that seen in studies with perfused whole pancreas (20) and thus may more accurately reflect in vivo islet physiology. Additionally, the Western blotting procedure used in our experiments is more sensitive than the PKC enzyme assays used in the previous studies, requiring as few as 30 islets to obtain a strong a-PKC signal. Thus the use of a highly sensitive Western blotting technique on freshly isolated, perifused rat islets that exhibited a brisk biphasic insulin secretory response to glucose may explain why we were able to detect translocation of a-PKC in our experiments.
We have demonstrated that the biphasic insulin secretory response to the fuel molecule KIC is associated with a translocation of a-PKC from the cytosol to the membrane. Moreover, neither the secretory response nor the translocation of a-PKC was blocked by the addition of mannoheptulose, which does not interfere with the metabolism of KIC.
Presumably, the translocation of a-PKC that was observed in response to either glucose or KIC was associated with the accumulation of diacylglycerol in the islets. Studies by PeterReisch et al. (4) and by Wolf et al. (5) have demonstrated the accumulation of diacylglycerol in cultured rat islets that were exposed to high glucose concentrations. Data from both these studies suggest that the bulk of this diacylglycerol may be produced by de novo synthesis from glycolytic intermediates generated by the metabolism of glucose. Since KIC, the keto-acid derivative of leucine, yields neither pyruvate nor a Proc. Natl. Acad. Sci. USA 87 (1990) u -I I J glycolytic intermediate during its oxidative degradation, it cannot serve as a source for the de novo synthesis of diacylglycerol. Thus KIC can induce biphasic insulin secretion and translocation of PKC without causing de novo synthesis of diacylglycerol. This conclusion argues that the de novo synthesis of diacylglycerol may not be required for fuel-induced insulin secretion. It has been reported that both KIC (21) and glucose (22) induce a calcium-dependent increase in inositolphospholipid hydrolysis in isolated islets. This pathway of diacylglycerol formation may be the more important one in mediating the translocation of a-PKC.
The insulin secretory patterns seen in response to 1 AuM PMA, 20 mM glucose, and 15 mM KIC are quite different, although the degree of a-PKC translocation induced by these three agonists is similar. This result is not surprising, as these agonists may differentially affect other intracellular signals involved in the regulation of insulin secretion. It has been reported that the combination of PMA with tolbutamide, an agent which increases calcium influx, induces a biphasic pattern of insulin secretion from pancreatic islets that is not seen with either agent alone (23) . The further addition of forskolin, which activates adenylate cyclase, increases the magnitude of this biphasic response, although forskolin by itself causes only a small increase in insulin secretion (23) . The metabolism of glucose in beta cells increases cAMP levels, increases calcium influx, may activate phospholipase A2, and modulates dihydropyridine-sensitive calcium channels (24, 25) . All of these signals may synergistically interact with the translocation of PKC to produce a biphasic pattern of insulin secretion (26) . At the concentrations used in this study, KIC may not be as effective in generating these other signals as is glucose, and thus KIC evokes a smaller increase in insulin secretory rate than does glucose, even though KIC induces a similar degree of a-PKC translocation.
It must be emphasized that although we have shown that the translocation of a-PKC is associated with insulin secretion at stimulatory glucose concentrations, we have not demonstrated that this translocation is a necessary step in triggering glucose-induced insulin secretion. It is reasonable to infer that the redistributed a-PKC is catalytically active, as calcium influx is increased by glucose, and in vitro, membrane-associated PKC is active in the presence of nanomolar to micromolar concentrations of calcium (1, 24) . However, further studies are needed to establish a causal link between PKC translocation by glucose and insulin secretion. 
